sh-vector-shutterstock-com-1
SH-Vector / Shutterstock.com
10 September 2015PharmaClaire Phipps-Jones

London calling: the benefits of the UPC’s new home

The announcement on August 11 of the location of the London central division of the Unified Patent Court (UPC) should be welcomed by the life sciences sector. Not only is the new court at Aldgate Tower in the middle of legal London and a stone’s throw from MedCity (the organisation managing a life sciences cluster including London, Cambridge and Oxford), it’s also easily accessible to the hotbed of innovators and manufacturers based in London and the south-east and to international court users alike.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
9 July 2026   Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.
Pharma
7 July 2026   Leading women from the pharmaceutical and biotechnology sectors are among the more than 100 professionals recognised in a newly released Influential Women in IP 2026 list, which celebrates leadership, expertise and innovation.
Pharma
1 July 2026   Otsuka v Sun Pharma could redefine which pharmaceutical patents qualify for patent term extensions, with major implications for innovator companies, generic manufacturers and the future of market exclusivity in the country.